"We have identified a group of patients with a necrotizing myopathy and a novel anti-200/100 autoantibody specificity," said Dr. Andrew Mammen, M.D., Ph.D., and lead author of the study.

Necrotizing myopathy: muscle weakness. Polymyalgia rheumatica occurs more commonly in older persons and preferentially affects the proximal muscles with markedly elevated measures of inflammation ...

Pain is common among patients with IIMs and is linked to worse physical function, increased fatigue, and reduced quality of life.

Title: Correlative Studies of CABA-201 in Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus Date and Time: November 16, 2024, 10:30 a.m. – 12:30 p.m. ET ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced key updates on its RESET-Myositis trial and plans for the anticipated 2027 Biologics License Application (BLA) submission for ...

As such, they are orienting the RESET-Myositis trial to focus on two cohorts of patients: those with dermatomyositis or antisynthetase syndrome, and those with immune-mediated necrotizing myopathy.

A memorial benefit for Jon Peterson will be held from 11 a.m. to 2 p.m. Sunday, Oct. 20, at Labby's, 1100 19th Ave. N., Fargo. Proceeds from the free-will lunch, silent, online, and live auctions ...

On December 13th, Gregory Charles Harrass entered his eternal rest following an eight year long battle against necrotizing myopathy and cirrhosis of the liver. He is survived by the love of his ...

Five of the main subtypes include dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, polymyositis, and overlap myositis, all of which can lead to significant ...

Myositis in general affects 50,000 to 75,000 people in the U.S., but the statin-triggered type Furlan had — called HMGCR necrotizing myopathy — is seen in only two or three out of 100,000 ...

Idiopathic myopathies include polymyositis, dermatomyositis, non-specific myositis, and necrotizing myopathy. 1 These are very rare conditions and may be missed if one is unfamiliar with the ...

REDWOOD CITY, Calif. & BOSTON, October 16, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...